Ultragenyx Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 10.65 M | $355.75 M | 45.96% | 10.46% |
| RTW INVESTMENTS, LP | 08/14/2026 | 7.80 M | $260.34 M | 113.68% | 7.65% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 6.79 M | $226.72 M | 26.07% | 6.66% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 6.56 M | $214.14 M | 43.31% | 6.44% |
| STATE STREET CORP | 08/07/2026 | 6.16 M | $205.64 M | 22.65% | 6.04% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.30 M | $143.46 M | 2.55% | 4.22% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 3.62 M | $120.91 M | 64.17% | 3.55% |
| SANDS CAPITAL MANAGEMENT, LLC | 08/13/2026 | 3.16 M | $105.46 M | -1.75% | 3.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 2.94 M | $98.16 M | 105.42% | 2.88% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 08/14/2026 | 2.85 M | $95.09 M | 29.97% | 2.79% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.58 M | $86.12 M | 39.44% | 2.53% |
| BELLEVUE GROUP AG | 08/14/2026 | 1.98 M | $66.20 M | -16.69% | 1.95% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.73 M | $57.77 M | 37.21% | 1.70% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 1.72 M | $57.35 M | -45.40% | 1.69% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 1.58 M | $52.76 M | 229.17% | 1.55% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 1.48 M | $49.46 M | -8.31% | 1.45% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 1.42 M | $47.35 M | 100.00% | 1.39% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.36 M | $45.30 M | 68.70% | 1.33% |
| MORGAN STANLEY | 08/13/2026 | 1.32 M | $44.24 M | -11.71% | 1.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 1.25 M | $41.75 M | -52.65% | 1.23% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 1.24 M | $41.46 M | -12.99% | 1.22% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.15 M | $38.35 M | 9.74% | 1.13% |
| CANDRIAM S.C.A. | 08/13/2026 | 1.00 M | $33.42 M | -8.61% | 0.98% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 967.86 K | $32.32 M | -20.59% | 0.95% |
| JEFFERIES FINANCIAL GROUP INC. | 08/17/2026 | 929.63 K | $31.04 M | 5,902.23% | 0.91% |
| NORTHERN TRUST CORP | 08/13/2026 | 920.31 K | $30.73 M | 71.84% | 0.90% |
| EAGLE HEALTH INVESTMENTS LP | 08/10/2026 | 884.12 K | $29.52 M | 0.00% | 0.87% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 882.22 K | $29.46 M | -3.56% | 0.87% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 784.10 K | $26.18 M | 94.59% | 0.77% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 760.83 K | $25.40 M | -57.07% | 0.75% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 760.04 K | $25.38 M | 36.09% | 0.75% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 760.04 K | $25.38 M | 100.00% | 0.75% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 753.70 K | $23.16 M | 24.87% | 0.74% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 718.80 K | $24.00 M | 147.86% | 0.71% |
| NUVEEN, LLC | 08/11/2026 | 693.96 K | $23.17 M | 4.82% | 0.68% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 671.41 K | $22.42 M | 10.39% | 0.66% |
| UBS GROUP AG | 08/13/2026 | 657.70 K | $21.96 M | -21.02% | 0.65% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 600.00 K | $20.03 M | 100.00% | 0.59% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 596.50 K | $19.92 M | 0.00% | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 588.49 K | $19.65 M | -27.29% | 0.58% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 586.52 K | $19.58 M | -0.64% | 0.58% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 586.23 K | $19.57 M | 100.00% | 0.58% |
| FMR LLC | 08/13/2026 | 576.85 K | $19.26 M | 100.77% | 0.57% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 575.34 K | $19.21 M | 62.94% | 0.56% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 556.39 K | $18.58 M | 42.86% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 509.00 K | $17.00 M | 38.65% | 0.50% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 500.00 K | $16.70 M | 42.86% | 0.49% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 498.17 K | $16.63 M | 1.50% | 0.49% |
| JPMORGAN CHASE & CO | 08/12/2026 | 493.13 K | $15.27 M | 100.52% | 0.48% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 470.70 K | $15.72 M | 37.98% | 0.46% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ultragenyx Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 460 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 10.65 M
RTW INVESTMENTS, LP: 7.8 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 6.79 M
AQR CAPITAL MANAGEMENT LLC: 6.56 M
STATE STREET CORP: 6.16 M
VANGUARD CAPITAL MANAGEMENT LLC: 4.3 M
105.45% of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 133.15 M shares in the last 24 months. This purchase volume represents approximately $3.01 B in transactions.